1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : PHARMACEUTICALS
  4. GLENMARK PHARMACEUTICALS LTD.
Glenmark Pharmaceuticals Ltd. NSE: GLENMARK | BSE: 532296
2181.50 0.40 (0.02%)
892.5K

NSE 14 Jul, 2025 9:35 AM (IST)

Signs Agreement
Glenmark rises as it licenses its cancer drug, ISB-2001, to AbbVie for up to $1.9 bn, royalties See details


Glenmark Pharmaceuticals Ltd. Earnings/Conference Calls

Glenmark Pharmaceuticals Ltd. earnings concalls and investor presentations

568 Votes:
Buy 79.23%
Sell 13.73%
Hold 7.04%
BUY
SELL
HOLD